19 C
New York
August 18, 2022

Access to experimental monkeypox treatment remains uneven, doctors say

A drug is available for monkeypox patients who have or who are at risk of severe disease, but doctors say they continue to face challenges getting access to it. The U.S. Food and Drug Administration hasn’t approved tecovirimat — sold under the brand name Tpoxx — specifically for use against monkeypox, but the U.S. Centers for Disease Control and Prevention has made the drug available. Source

Related posts

Firefighter loses life after wall collapses in burning building: Union


Quebec solidaire issues climate change ultimatum to CAQ


Demonstrators arrive for another round of Quebec City ‘freedom’ protests


Leave a Comment